Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Richard Moore

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Living Beings

HIV-1

Geographic Areas

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Balagopal Ashwin; Ray Stuart C; De Oca Ruben Montes; Sutcliffe Catherine G; Vivekanandan Perumal; Higgins Yvonne; Mehta Shruti H; Moore Richard D; Sulkowski Mark S; Thomas David L; Torbenson Michael S
Kupffer cells are depleted with HIV immunodeficiency and partially recovered with antiretroviral immune reconstitution.
Grinsztejn Beatriz; Veloso Valdilea G; Friedman Ruth K; Moreira Ronaldo I; Luz Paula M; Campos Dayse P; Pilotto José H; Cardoso Sandra W; Keruly Jeanne C; Moore Richard D
Early mortality and cause of deaths in patients using HAART in Brazil and the United States.
Gallant Joel E; Moore Richard D
Renal function with use of a tenofovir-containing initial antiretroviral regimen.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Richard Moore (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Balagopal Ashwin; Ray Stuart C; De Oca Ruben Montes; Sutcliffe Catherine G; Vivekanandan Perumal; Higgins Yvonne; Mehta Shruti H; Moore Richard D; Sulkowski Mark S; Thomas David L; Torbenson Michael S
Kupffer cells are depleted with HIV immunodeficiency and partially recovered with antiretroviral immune reconstitution.
AIDS (London, England) 2009;23(18):2397-404.
2009: Grinsztejn Beatriz; Veloso Valdilea G; Friedman Ruth K; Moreira Ronaldo I; Luz Paula M; Campos Dayse P; Pilotto José H; Cardoso Sandra W; Keruly Jeanne C; Moore Richard D
Early mortality and cause of deaths in patients using HAART in Brazil and the United States.
AIDS (London, England) 2009;23(16):2107-14.
2009: Gallant Joel E; Moore Richard D
Renal function with use of a tenofovir-containing initial antiretroviral regimen.
AIDS (London, England) 2009;23(15):1971-5.
2009: Lau Bryan; Gange Stephen J; Kirk Gregory D; Moore Richard D
Evaluation of human immunodeficiency virus biomarkers: inferences from interval and clinical cohort studies.
Epidemiology (Cambridge, Mass.) 2009;20(5):664-72.
2009: McOliver Cynthia C; Lemerman Hanna B; Silbergeld Ellen K; Moore Richard D; Graczyk Thaddeus K
Risks of recreational exposure to waterborne pathogens among persons with HIV/AIDS in Baltimore, Maryland.
American journal of public health 2009;99(6):1116-22.
2009: Chander Geetanjali; Himelhoch Seth; Fleishman John A; Hellinger James; Gaist Paul; Moore Richard D; Gebo Kelly A
HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use.
AIDS care 2009;21(5):655-63.
2009: Kitahata Mari M; Gange Stephen J; Abraham Alison G; Merriman Barry; Saag Michael S; Justice Amy C; Hogg Robert S; Deeks Steven G; Eron Joseph J; Brooks John T; Rourke Sean B; Gill M John; Bosch Ronald J; Martin Jeffrey N; Klein Marina B; Jacobson Lisa P; Rodriguez Benigno; Sterling Timothy R; Kirk Gregory D; Napravnik Sonia; Rachlis Anita R; Calzavara Liviana M; Horberg Michael A; Silverberg Michael J; Gebo Kelly A; Goedert James J; Benson Constance A; Collier Ann C; Van Rompaey Stephen E; Crane Heidi M; McKaig Rosemary G; Lau Bryan; Freeman Aimee M; Moore Richard D;
Effect of early versus deferred antiretroviral therapy for HIV on survival.
The New England journal of medicine 2009;360(18):1815-26.
2009: Kirk Gregory D; Astemborski Jacquie; Mehta Shruti H; Spoler Chuck; Fisher Cedric; Allen Danisha; Higgins Yvonne; Moore Richard D; Afdhal Nezem; Torbenson Michael; Sulkowski Mark; Thomas David L
Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(7):963-72.
2009: Chaudhry A A; Sulkowski M S; Chander G; Moore R D
Hazardous drinking is associated with an elevated aspartate aminotransferase to platelet ratio index in an urban HIV-infected clinical cohort.
HIV medicine 2009;10(3):133-42.
2009: Ghanem Khalil G; Moore Richard D; Rompalo Anne M; Erbelding Emily J; Zenilman Jonathan M; Gebo Kelly A
Lumbar puncture in HIV-infected patients with syphilis and no neurologic symptoms.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2009;48(6):816-21.
2009: Moore Richard D
Excess mortality after HIV seroconversion has greatly decreased in the past 10 years.
Evidence-based medicine 2009;14(1):23.
2008: Yehia Baligh R; Gebo Kelly A; Hicks Perrin B; Korthuis P Todd; Moore Richard D; Ridore Michelande; Mathews William Christopher;
Structures of care in the clinics of the HIV Research Network.
AIDS patient care and STDs 2008;22(12):1007-13.
2008: Tello Monique A; Yeh Hsin-Chieh; Keller Jean M; Beach Mary C; Anderson Jean R; Moore Richard D
HIV women's health: a study of gynecological healthcare service utilization in a U.S. urban clinic population.
Journal of women's health (2002) 2008;17(10):1609-14.
2008: Korthuis P Todd; Saha Somnath; Fleishman John A; McGrath Moriah McSharry; Josephs Joshua S; Moore Richard D; Gebo Kelly A; Hellinger James; Beach Mary Catherine;
Impact of patient race on patient experiences of access and communication in HIV care.
Journal of general internal medicine 2008;23(12):2046-52.
2008: Moore Richard D
Excess mortality after HIV seroconversion has greatly decreased in the past 10 years.
ACP journal club 2008;149(5):15.
2008: Golub Jonathan E; Durovni Betina; King Bonnie S; Cavalacante Solange C; Pacheco Antonio G; Moulton Lawrence H; Moore Richard D; Chaisson Richard E; Saraceni Valeria
Recurrent tuberculosis in HIV-infected patients in Rio de Janeiro, Brazil.
AIDS (London, England) 2008;22(18):2527-33.
2008: Greenbaum Adena H; Wilson Lucy E; Keruly Jeanne C; Moore Richard D; Gebo Kelly A
Effect of age and HAART regimen on clinical response in an urban cohort of HIV-infected individuals.
AIDS (London, England) 2008;22(17):2331-9.
2008: Burkey M D; Wilson L E; Moore R D; Lucas G M; Francis J; Gebo K A
The incidence of and risk factors for MRSA bacteraemia in an HIV-infected cohort in the HAART era.
HIV medicine 2008;9(10):858-62.
2008: Petersen Maya L; van der Laan Mark J; Napravnik Sonia; Eron Joseph J; Moore Richard D; Deeks Steven G
Long-term consequences of the delay between virologic failure of highly active antiretroviral therapy and regimen modification.
AIDS (London, England) 2008;22(16):2097-106.
2008: Moore Richard D; Gebo Kelly A; Lucas Gregory M; Keruly Jeanne C
Rate of comorbidities not related to HIV infection or AIDS among HIV-infected patients, by CD4 cell count and HAART use status.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;47(8):1102-4.
2008: Page Kathleen R; Moore Richard D; Wilgus Barbara; Gindi Renee; Erbelding Emily J
Neisseria gonorrhoeae and Chlamydia trachomatis among human immunodeficiency virus-infected women.
Sexually transmitted diseases 2008;35(10):859-61.
2008: Shapiro Nathan I; Wolfe Richard E; Wright Sharon B; Moore Richard; Bates David W
Who needs a blood culture? A prospectively derived and validated prediction rule.
The Journal of emergency medicine 2008;35(3):255-64.
2008: Kitahata Mari M; Rodriguez Benigno; Haubrich Richard; Boswell Stephen; Mathews W Christopher; Lederman Michael M; Lober William B; Van Rompaey Stephen E; Crane Heidi M; Moore Richard D; Bertram Michael; Kahn James O; Saag Michael S
Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems.
International journal of epidemiology 2008;37(5):948-55.
2008: Lau Bryan; Cole Stephen R; Moore Richard D; Gange Stephen J
Evaluating competing adverse and beneficial outcomes using a mixture model.
Statistics in medicine 2008;27(21):4313-27.
2008: Lutwama Fred; Serwadda Ronnie; Mayanja-Kizza Harriet; Shihab Hasan M; Ronald Allan; Kamya Moses R; Thomas David; Johnson Elizabeth; Quinn Thomas C; Moore Richard D; Spacek Lisa A
Evaluation of Dynabeads and Cytospheres compared with flow cytometry to enumerate CD4+ T cells in HIV-infected Ugandans on antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2008;48(3):297-303.
2008: Ghanem Khalil G; Moore Richard D; Rompalo Anne M; Erbelding Emily J; Zenilman Jonathan M; Gebo Kelly A
Antiretroviral therapy is associated with reduced serologic failure rates for syphilis among HIV-infected patients.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;47(2):258-65.
2008: Ahonkhai Aima A; Gebo Kelly A; Streiff Michael B; Moore Richard D; Segal Jodi B
Venous thromboembolism in patients with HIV/AIDS: a case-control study.
Journal of acquired immune deficiency syndromes (1999) 2008;48(3):310-4.
2008: Ghanem Khalil G; Moore Richard D; Rompalo Anne M; Erbelding Emily J; Zenilman Jonathan M; Gebo Kelly A
Neurosyphilis in a clinical cohort of HIV-1-infected patients.
AIDS (London, England) 2008;22(10):1145-51.
2008: Lucas Gregory M; Lau Bryan; Atta Mohamed G; Fine Derek M; Keruly Jeanne; Moore Richard D
Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races.
The Journal of infectious diseases 2008;197(11):1548-57.
2008: Koethe John R; Moore Richard D; Wagner Krystn R
Physician specialization and women's primary care services in an urban HIV clinic.
AIDS patient care and STDs 2008;22(5):373-80.
2008: Long Jessica L; Engels Eric A; Moore Richard D; Gebo Kelly A
Incidence and outcomes of malignancy in the HAART era in an urban cohort of HIV-infected individuals.
AIDS (London, England) 2008;22(4):489-96.
2008: Riedel David J; Gebo Kelly A; Moore Richard D; Lucas Gregory M
A ten-year analysis of the incidence and risk factors for acute pancreatitis requiring hospitalization in an urban HIV clinical cohort.
AIDS patient care and STDs 2008;22(2):113-21.
2008: Fleishman John A; Moore Richard D; Conviser Richard; Lawrence Perrin B; Korthuis P Todd; Gebo Kelly A
Associations between outpatient and inpatient service use among persons with HIV infection: a positive or negative relationship?
Health services research 2008;43(1 Pt 1):76-95.
2008: Pacheco Antonio G; Durovni Betina; Cavalcante Solange C; Lauria L M; Moore Richard D; Moulton Lawrence H; Chaisson Richard E; Golub Jonathan E
AIDS-related tuberculosis in Rio de Janeiro, Brazil.
PloS one 2008;3(9):e3132.
2007: Atta Mohamed G; Fine Derek M; Kirk Gregory D; Mehta Shruti H; Moore Richard D; Lucas Gregory M
Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45(12):1625-32.
2007: Manabe Yukari C; Campbell James D; Sydnor Emily; Moore Richard D
Immune reconstitution inflammatory syndrome: risk factors and treatment implications.
Journal of acquired immune deficiency syndromes (1999) 2007;46(4):456-62.
2007: Lucas Gregory M; Mehta Shruti H; Atta Mohamed G; Kirk Gregory D; Galai Noya; Vlahov David; Moore Richard D
End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004.
AIDS (London, England) 2007;21(18):2435-43.
2007: Keruly Jeanne C; Moore Richard D
Immune status at presentation to care did not improve among antiretroviral-naive persons from 1990 to 2006.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45(10):1369-74.
2007: Sulkowski Mark S; Mehta Shruti H; Torbenson Michael S; Higgins Yvonne; Brinkley Sherilyn C; de Oca Ruben Montes; Moore Richard D; Afdhal Nezam H; Thomas David L
Rapid fibrosis progression among HIV/hepatitis C virus-co-infected adults.
AIDS (London, England) 2007;21(16):2209-16.
2007: Patterson K; Napravnik S; Eron J; Keruly J; Moore R
Effects of age and sex on immunological and virological responses to initial highly active antiretroviral therapy.
HIV medicine 2007;8(6):406-10.
2007: Lucas Gregory M; Mullen B Anna; McCaul Mary E; Weidle Paul J; Hader Shannon; Moore Richard D
Adherence, drug use, and treatment failure in a methadone-clinic-based program of directly administered antiretroviral therapy.
AIDS patient care and STDs 2007;21(8):564-74.
2007: Grinsztejn Beatriz; Veloso Valdilea G; Pilotto José Henrique; Campos Dayse Pereira; Keruly Jeanne C; Moore Richard D
Comparison of clinical response to initial highly active antiretroviral therapy in the patients in clinical care in the United States and Brazil.
Journal of acquired immune deficiency syndromes (1999) 2007;45(5):515-20.
2007: Beach Mary Catherine; Duggan Patrick S; Moore Richard D
Is patients' preferred involvement in health decisions related to outcomes for patients with HIV?
Journal of general internal medicine 2007;22(8):1119-24.
2007: Golub Jonathan E; Saraceni Valeria; Cavalcante Solange C; Pacheco Antonio G; Moulton Lawrence H; King Bonnie S; Efron Anne; Moore Richard D; Chaisson Richard E; Durovni Betina
The impact of antiretroviral therapy and isoniazid preventive therapy on tuberculosis incidence in HIV-infected patients in Rio de Janeiro, Brazil.
AIDS (London, England) 2007;21(11):1441-8.
2007: Lau Bryan; Gange Stephen J; Moore Richard D
Interval and clinical cohort studies: epidemiological issues.
AIDS research and human retroviruses 2007;23(6):769-76.
2007: Gange Stephen J; Kitahata Mari M; Saag Michael S; Bangsberg David R; Bosch Ronald J; Brooks John T; Calzavara Liviana; Deeks Steven G; Eron Joseph J; Gebo Kelly A; Gill M John; Haas David W; Hogg Robert S; Horberg Michael A; Jacobson Lisa P; Justice Amy C; Kirk Gregory D; Klein Marina B; Martin Jeffrey N; McKaig Rosemary G; Rodriguez Benigno; Rourke Sean B; Sterling Timothy R; Freeman Aimee M; Moore Richard D
Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD).
International journal of epidemiology 2007;36(2):294-301.
2007: Siliciano Janet D; Lai Jun; Callender Marc; Pitt Eleanor; Zhang Hao; Margolick Joseph B; Gallant Joel E; Cofrancesco Joseph; Moore Richard D; Gange Stephen J; Siliciano Robert F
Stability of the latent reservoir for HIV-1 in patients receiving valproic acid.
The Journal of infectious diseases 2007;195(6):833-6.
2007: Moore Richard D; Keruly Jeanne C
CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;44(3):441-6.
2007: Lau Bryan; Gange Stephen J; Moore Richard D
Risk of non-AIDS-related mortality may exceed risk of AIDS-related mortality among individuals enrolling into care with CD4+ counts greater than 200 cells/mm3.
Journal of acquired immune deficiency syndromes (1999) 2007;44(2):179-87.
2006: Gebo Kelly A; Burkey Matthew D; Lucas Gregory M; Moore Richard D; Wilson Lucy E
Incidence of, risk factors for, clinical presentation, and 1-year outcomes of infective endocarditis in an urban HIV cohort.
Journal of acquired immune deficiency syndromes (1999) 2006;43(4):426-32.
2006: Chander Geetanjali; Lau Bryan; Moore Richard D
Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection.
Journal of acquired immune deficiency syndromes (1999) 2006;43(4):411-7.
2006: Mehta Shruti H; Lucas Gregory M; Mirel Lisa B; Torbenson Michael; Higgins Yvonne; Moore Richard D; Thomas David L; Sulkowski Mark S
Limited effectiveness of antiviral treatment for hepatitis C in an urban HIV clinic.
AIDS (London, England) 2006;20(18):2361-9.
2006: Schackman Bruce R; Gebo Kelly A; Walensky Rochelle P; Losina Elena; Muccio Tammy; Sax Paul E; Weinstein Milton C; Seage George R; Moore Richard D; Freedberg Kenneth A
The lifetime cost of current human immunodeficiency virus care in the United States.
Medical care 2006;44(11):990-7.
2006: Brock Malcolm V; Hooker Craig M; Engels Eric A; Moore Richard D; Gillison Maura L; Alberg Anthony J; Keruly Jeanne C; Yang Stephen C; Heitmiller Richard F; Baylin Stephen B; Herman James G; Brahmer Julie R
Delayed diagnosis and elevated mortality in an urban population with HIV and lung cancer: implications for patient care.
Journal of acquired immune deficiency syndromes (1999) 2006;43(1):47-55.
2006: Beach Mary Catherine; Keruly Jeanne; Moore Richard D
Is the quality of the patient-provider relationship associated with better adherence and health outcomes for patients with HIV?
Journal of general internal medicine 2006;21(6):661-5.
2006: Lucas Gregory M; Mullen B Anna; Weidle Paul J; Hader Shannon; McCaul Mary E; Moore Richard D
Directly administered antiretroviral therapy in methadone clinics is associated with improved HIV treatment outcomes, compared with outcomes among concurrent comparison groups.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(11):1628-35.
2006: Sheth Anandi N; Moore Richard D; Gebo Kelly A
Provision of general and HIV-specific health maintenance in middle aged and older patients in an urban HIV clinic.
AIDS patient care and STDs 2006;20(5):318-25.
2006: Schechter Mauro; Zajdenverg Roberto; Falco Gisely; Barnes Grace Link; Faulhaber José Cláudio; Coberly Jacqueline S; Moore Richard D; Chaisson Richard E
Weekly rifapentine/isoniazid or daily rifampin/pyrazinamide for latent tuberculosis in household contacts.
American journal of respiratory and critical care medicine 2006;173(8):922-6.
2006: Cherry C L; Skolasky R L; Lal L; Creighton J; Hauer P; Raman S P; Moore R; Carter K; Thomas D; Ebenezer G J; Wesselingh S L; McArthur J C
Antiretroviral use and other risks for HIV-associated neuropathies in an international cohort.
Neurology 2006;66(6):867-73.
2006: Engels Eric A; Brock Malcolm V; Chen Jinbo; Hooker Craig M; Gillison Maura; Moore Richard D
Elevated incidence of lung cancer among HIV-infected individuals.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(9):1383-8.
2006: Lucas Gregory M; Griswold Michael; Gebo Kelly A; Keruly Jeanne; Chaisson Richard E; Moore Richard D
Illicit drug use and HIV-1 disease progression: a longitudinal study in the era of highly active antiretroviral therapy.
American journal of epidemiology 2006;163(5):412-20.
2006: Barry Pennan M; Zetola Nicola; Keruly Jeanne C; Moore Richard D; Gebo Kelly A; Lucas Gregory M
Invasive pneumococcal disease in a cohort of HIV-infected adults: incidence and risk factors, 1990-2003.
AIDS (London, England) 2006;20(3):437-44.
2006: Spacek Lisa A; Shihab Hasan M; Kamya Moses R; Mwesigire Doris; Ronald Allan; Mayanja Harriet; Moore Richard D; Bates Michael; Quinn Thomas C
Response to antiretroviral therapy in HIV-infected patients attending a public, urban clinic in Kampala, Uganda.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(2):252-9.
2006: Chander Geetanjali; Himelhoch Seth; Moore Richard D
Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy.
Drugs 2006;66(6):769-89.
2005: Gebo Kelly A; Fleishman John A; Moore Richard D
Hospitalizations for metabolic conditions, opportunistic infections, and injection drug use among HIV patients: trends between 1996 and 2000 in 12 states.
Journal of acquired immune deficiency syndromes (1999) 2005;40(5):609-16.
2005: Gebo Kelly A; Kalyani Rita; Moore Richard D; Polydefkis Michael J
The incidence of, risk factors for, and sequelae of herpes zoster among HIV patients in the highly active antiretroviral therapy era.
Journal of acquired immune deficiency syndromes (1999) 2005;40(2):169-74.
2005: Fleishman John A; Gebo Kelly A; Reilly Erin D; Conviser Richard; Christopher Mathews W; Todd Korthuis P; Hellinger James; Rutstein Richard; Keiser Philip; Rubin Haya; Moore Richard D;
Hospital and outpatient health services utilization among HIV-infected adults in care 2000-2002.
Medical care 2005;43(9 Suppl):III40-52.
2005: Gebo Kelly A; Fleishman John A; Reilly Erin D; Moore Richard D;
High rates of primary Mycobacterium avium complex and Pneumocystis jiroveci prophylaxis in the United States.
Medical care 2005;43(9 Suppl):III23-30.
2005: Moore Richard D; Cofrancesco Joseph
Report from Boston: the 12th Conference on Retroviruses and Opportunistic Infections (CROI). February 22-25, 2005. Complications/toxicity of HIV therapy.
HIV clinical trials 2005;6(4):229-34.
2005: Karmon S L; Moore R D; Dobs A S; Keruly J; Barnett S; Cofrancesco J
Body shape and composition in HIV-infected women: an urban cohort.
HIV medicine 2005;6(4):245-52.
2005: Moore Richard D; Keruly Jeanne C; Gebo Kelly A; Lucas Gregory M
An improvement in virologic response to highly active antiretroviral therapy in clinical practice from 1996 through 2002.
Journal of acquired immune deficiency syndromes (1999) 2005;39(2):195-8.
2005: Moore Richard D; Confrancesco Joseph
Report from Boston: the 12th Conference on Retroviruses and Opportunistic Infections (CROI). Complications/toxicity of HIV therapy.
The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service 2005;17(3):1-5, 9.
2005: Gallant Joel E; Parish Michelle A; Keruly Jeanne C; Moore Richard D
Changes in renal function associated with tenofovir disoproxil fumarate treatment, compared with nucleoside reverse-transcriptase inhibitor treatment.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;40(8):1194-8.
2005: Sulkowski Mark S; Mehta Shruti H; Torbenson Michael; Afdhal Nezam H; Mirel Lisa; Moore Richard D; Thomas David L
Hepatic steatosis and antiretroviral drug use among adults coinfected with HIV and hepatitis C virus.
AIDS (London, England) 2005;19(6):585-92.
2005: Iloeje U H; Yuan Y; L'italien G; Mauskopf J; Holmberg S D; Moorman A C; Wood K C; Moore R D
Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients.
HIV medicine 2005;6(1):37-44.
2005: Mehta Shruti H; Thomas David L; Torbenson Michael; Brinkley Sherilyn; Mirel Lisa; Chaisson Richard E; Moore Richard D; Sulkowski Mark S
The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection.
Hepatology (Baltimore, Md.) 2005;41(1):123-31.
2005: Gebo Kelly A; Fleishman John A; Conviser Richard; Reilly Erin D; Korthuis P Todd; Moore Richard D; Hellinger James; Keiser Philip; Rubin Haya R; Crane Lawrence; Hellinger Fred J; Mathews W Christopher;
Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001.
Journal of acquired immune deficiency syndromes (1999) 2005;38(1):96-103.
2004: Himelhoch Seth; Moore Richard D; Treisman Glenn; Gebo Kelly A
Does the presence of a current psychiatric disorder in AIDS patients affect the initiation of antiretroviral treatment and duration of therapy?
Journal of acquired immune deficiency syndromes (1999) 2004;37(4):1457-63.
2004: Sulkowski Mark S; Mehta Shruti H; Chaisson Richard E; Thomas David L; Moore Richard D
Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavir.
AIDS (London, England) 2004;18(17):2277-84.
2004: Gebo Kelly A; Moore Richard D
Treatment of HIV infection in the older patient.
Expert review of anti-infective therapy 2004;2(5):733-43.
2004: Nettles Richard E; Kieffer Tara L; Simmons Rachel P; Cofrancesco Joseph; Moore Richard D; Gallant Joel E; Persaud Deborah; Siliciano Robert F
Genotypic resistance in HIV-1-infected patients with persistently detectable low-level viremia while receiving highly active antiretroviral therapy.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(7):1030-7.
2004: Karakousis Petros C; Moore Richard D; Chaisson Richard E
Mycobacterium avium complex in patients with HIV infection in the era of highly active antiretroviral therapy.
The Lancet infectious diseases 2004;4(9):557-65.
2004: Gebo Kelly A; Gallant Joel E; Keruly Jeanne C; Moore Richard D
Absolute CD4 vs. CD4 percentage for predicting the risk of opportunistic illness in HIV infection.
Journal of acquired immune deficiency syndromes (1999) 2004;36(5):1028-33.
2004: Lucas Gregory M; Gallant Joel E; Moore Richard D
Relationship between drug resistance and HIV-1 disease progression or death in patients undergoing resistance testing.
AIDS (London, England) 2004;18(11):1539-48.
2004: Moore Richard D
Editorial comment: HAART and higher hemoglobin levels.
The AIDS reader 2004;14(6):314-5.
2004: Lucas Gregory M; Weidle Paul J; Hader Shannon; Moore Richard D
Directly administered antiretroviral therapy in an urban methadone maintenance clinic: a nonrandomized comparative study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;38 Suppl 5():S409-13.
2004: Lucas Gregory M; Eustace Joseph A; Sozio Stephen; Mentari Evelyn K; Appiah Kofi A; Moore Richard D
Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study.
AIDS (London, England) 2004;18(3):541-6.
2004: Moore Richard D; Keruly Jeanne C; Chaisson Richard E
Differences in HIV disease progression by injecting drug use in HIV-infected persons in care.
Journal of acquired immune deficiency syndromes (1999) 2004;35(1):46-51.
2003: Yu D Tony; Platt Richard; Lanken Paul N; Black Edgar; Sands Kenneth E; Schwartz J Sanford; Hibberd Patricia L; Graman Paul S; Kahn Katherine L; Snydman David R; Parsonnet Jeffrey; Moore Richard; Bates David W;
Relationship of pulmonary artery catheter use to mortality and resource utilization in patients with severe sepsis.
Critical care medicine 2003;31(12):2734-41.
2003: Sterling Timothy R; Chaisson Richard E; Keruly Jeanne; Moore Richard D
Improved outcomes with earlier initiation of highly active antiretroviral therapy among human immunodeficiency virus-infected patients who achieve durable virologic suppression: longer follow-up of an observational cohort study.
The Journal of infectious diseases 2003;188(11):1659-65.
2003: Gebo Kelly A; Moore Richard D; Fleishman John A
The HIV Research Network: a unique opportunity for real time clinical utilization analysis in HIV.
The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service 2003;15(6):5-6.
2003: Gebo Kelly A; Diener-West Marie; Moore Richard D
Hospitalization rates differ by hepatitis C satus in an urban HIV cohort.
Journal of acquired immune deficiency syndromes (1999) 2003;34(2):165-73.
2003: Sethi Ajay K; Celentano David D; Gange Stephen J; Moore Richard D; Gallant Joel E
Association between adherence to antiretroviral therapy and human immunodeficiency virus drug resistance.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;37(8):1112-8.
2003: Gray Ronald H; Li Xianbin; Wawer Maria J; Gange Stephen J; Serwadda David; Sewankambo Nelson K; Moore Richard; Wabwire-Mangen Fred; Lutalo Tom; Quinn Thomas C;
Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda.
AIDS (London, England) 2003;17(13):1941-51.
2003: Mehta Shruti H; Moore Richard D; Thomas David L; Chaisson Richard E; Sulkowski Mark S
The effect of HAART and HCV infection on the development of hyperglycemia among HIV-infected persons.
Journal of acquired immune deficiency syndromes (1999) 2003;33(5):577-84.
2003: Marconi Katherine; Moore Richard
Commentary: the importance of demonstrations in developing adolescent HIV care models.
The Journal of adolescent health : official publication of the Society for Adolescent Medicine 2003;33(2 Suppl):1-3.
2003: Lucas Gregory M; Chaisson Richard E; Moore Richard D
Survival in an urban HIV-1 clinic in the era of highly active antiretroviral therapy: a 5-year cohort study.
Journal of acquired immune deficiency syndromes (1999) 2003;33(3):321-8.
2003: Yan Yan; Hoover Donald R; Moore Richard D; Xiong Chengjie
Multivariate estimation of cumulative incidence, prevalence, and morbidity time of a disease when death is likely.
Journal of clinical epidemiology 2003;56(6):546-52.
2003: Spacek Lisa A; Griswold Michael; Quinn Thomas C; Moore Richard D
Total lymphocyte count and hemoglobin combined in an algorithm to initiate the use of highly active antiretroviral therapy in resource-limited settings.
AIDS (London, England) 2003;17(9):1311-7.
2003: Yu D Tony; Black Edgar; Sands Kenneth E; Schwartz J Sanford; Hibberd Patricia L; Graman Paul S; Lanken Paul N; Kahn Katherine L; Snydman David R; Parsonnet Jeffrey; Moore Richard; Platt Richard; Bates David W;
Severe sepsis: variation in resource and therapeutic modality use among academic centers.
Critical care (London, England) 2003;7(3):R24-34.
2003: Sterling Timothy R; Chaisson Richard E; Moore Richard D
Initiation of highly active antiretroviral therapy at CD4+ T lymphocyte counts of >350 cells/mm3: disease progression, treatment durability, and drug toxicity.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(6):812-5.
2003: Gebo Kelly A; Keruly Jeanne; Moore Richard D
Association of social stress, illicit drug use, and health beliefs with nonadherence to antiretroviral therapy.
Journal of general internal medicine 2003;18(2):104-11.
2003: Bates David W; Yu D Tony; Black Edgar; Sands Kenneth E; Schwartz J Sanford; Hibberd Patricia L; Graman Paul S; Lanken Paul N; Kahn Katherine L; Snydman David R; Parsonnet Jeffrey; Moore Richard; Platt Richard;
Resource utilization among patients with sepsis syndrome.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2003;24(1):62-70.
2003: Perez John L; Moore Richard D
Greater effect of highly active antiretroviral therapy on survival in people aged > or =50 years compared with younger people in an urban observational cohort.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(2):212-8.
2002: Lucas Gregory M; Flexner Charles W; Moore Richard D
Directly administered antiretroviral therapy in the treatment of HIV infection: benefit or burden?
AIDS patient care and STDs 2002;16(11):527-35.
2002: Sulkowski Mark S; Moore Richard D; Mehta Shruti H; Chaisson Richard E; Thomas David L
Hepatitis C and progression of HIV disease.
JAMA : the journal of the American Medical Association 2002;288(2):199-206.
2002: Keruly Jeanne C; Conviser Richard; Moore Richard D
Association of medical insurance and other factors with receipt of antiretroviral therapy.
American journal of public health 2002;92(5):852-7.
2002: Lucas Gregory M; Gebo Kelly A; Chaisson Richard E; Moore Richard D
Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic.
AIDS (London, England) 2002;16(5):767-74.
2002: Oursler Kris K; Moore Richard D; Bishai William R; Harrington Susan M; Pope Diana S; Chaisson Richard E
Survival of patients with pulmonary tuberculosis: clinical and molecular epidemiologic factors.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2002;34(6):752-9.
2002: Sulkowski Mark S; Thomas David L; Mehta Shruti H; Chaisson Richard E; Moore Richard D
Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections.
Hepatology (Baltimore, Md.) 2002;35(1):182-9.
2002: Moore Richard D; Forney Darrell
Anemia in HIV-infected patients receiving highly active antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2002;29(1):54-7.
2001: Sterling T R; Chaisson R E; Moore R D
HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy.
AIDS (London, England) 2001;15(17):2251-7.
2001: Keruly J C; Chaisson R E; Moore R D
Increasing incidence of avascular necrosis of the hip in HIV-infected patients.
Journal of acquired immune deficiency syndromes (1999) 2001;28(1):101-2.
2001: Lucas G M; Chaisson R E; Moore R D
Comparison of initial combination antiretroviral therapy with a single protease inhibitor, ritonavir and saquinavir, or efavirenz.
AIDS (London, England) 2001;15(13):1679-86.
2001: Lucas G M; Cheever L W; Chaisson R E; Moore R D
Detrimental effects of continued illicit drug use on the treatment of HIV-1 infection.
Journal of acquired immune deficiency syndromes (1999) 2001;27(3):251-9.
2001: Poundstone K E; Chaisson R E; Moore R D
Differences in HIV disease progression by injection drug use and by sex in the era of highly active antiretroviral therapy.
AIDS (London, England) 2001;15(9):1115-23.
2001: Gebo K A; Diener-West M; Moore R D
Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2001;27(2):143-52.
2001: Chaisson R E; Barnes G L; Hackman J; Watkinson L; Kimbrough L; Metha S; Cavalcante S; Moore R D
A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users.
The American journal of medicine 2001;110(8):610-5.
2001: Moore R D; Keruly J C; Chaisson R E
Incidence of pancreatitis in HIV-infected patients receiving nucleoside reverse transcriptase inhibitor drugs.
AIDS (London, England) 2001;15(5):617-20.
2001: McCaul M E; Svikis D S; Moore R D
Predictors of outpatient treatment retention: patient versus substance use characteristics.
Drug and alcohol dependence 2001;62(1):9-17.
2000: Chaisson R E; Keruly J C; Moore R D
Association of initial CD4 cell count and viral load with response to highly active antiretroviral therapy.
JAMA : the journal of the American Medical Association 2000;284(24):3128-9.
2000: Moore R D
Anemia and human immunodeficiency virus disease in the era of highly active antiretroviral therapy.
Seminars in hematology 2000;37(4 Suppl 6):18-23.
2000: Eustace J A; Nuermberger E; Choi M; Scheel P J; Moore R; Briggs W A
Cohort study of the treatment of severe HIV-associated nephropathy with corticosteroids.
Kidney international 2000;58(3):1253-60.
2000: Yan Y; Moore R D; Hoover D R
Competing risk adjustment reduces overestimation of opportunistic infection rates in AIDS.
Journal of clinical epidemiology 2000;53(8):817-22.
2000: Sullivan J H; Moore R D; Keruly J C; Chaisson R E
Effect of antiretroviral therapy on the incidence of bacterial pneumonia in patients with advanced HIV infection.
American journal of respiratory and critical care medicine 2000;162(1):64-7.
2000: Moore R D; Charache S; Terrin M L; Barton F B; Ballas S K
Cost-effectiveness of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
American journal of hematology 2000;64(1):26-31.
2000: Moore R D
Cost effectiveness of combination HIV therapy: 3 years later.
PharmacoEconomics 2000;17(4):325-30.
2000: Moore R D; Wong W M; Keruly J C; McArthur J C
Incidence of neuropathy in HIV-infected patients on monotherapy versus those on combination therapy with didanosine, stavudine and hydroxyurea.
AIDS (London, England) 2000;14(3):273-8.
2000: Sulkowski M S; Thomas D L; Chaisson R E; Moore R D
Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection.
JAMA : the journal of the American Medical Association 2000;283(1):74-80.
1999: Moore R D
HIV outcomes: natural history of HIV and economic impact.
The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service 1999;11(6):3, 10.
1999: Moore R D; Chaisson R E
Natural history of HIV infection in the era of combination antiretroviral therapy.
AIDS (London, England) 1999;13(14):1933-42.
1999: Bartlett J G; Moore R
A comprehensive plan for managed care of patients infected with human immunodeficiency virus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;29(1):50-5.
1999: Moore R D
Human immunodeficiency virus infection, anemia, and survival.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;29(1):44-9.
1999: Lucas G M; Chaisson R E; Moore R D
Highly active antiretroviral therapy in a large urban clinic: risk factors for virologic failure and adverse drug reactions.
Annals of internal medicine 1999;131(2):81-7.
1999: Hall C S; Raines C P; Barnett S H; Moore R D; Gallant J E
Efficacy of salvage therapy containing ritonavir and saquinavir after failure of single protease inhibitor-containing regimens.
AIDS (London, England) 1999;13(10):1207-12.
1999: Gebo K A; Chaisson R E; Folkemer J G; Bartlett J G; Moore R D
Costs of HIV medical care in the era of highly active antiretroviral therapy.
AIDS (London, England) 1999;13(8):963-9.
1999: Oursler K A; Moore R D; Chaisson R E
Risk factors for cryptococcal meningitis in HIV-infected patients.
AIDS research and human retroviruses 1999;15(7):625-31.
1999: Sterling T R; Brehm W T; Moore R D; Chaisson R E
Tuberculosis vaccination versus isoniazid preventive therapy: a decision analysis to determine the preferred strategy of tuberculosis prevention in HIV-infected adults in the developing world.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease 1999;3(3):248-54.
1999: Gallant J E; Chaisson R E; Keruly J C; Moore R D
Stavudine in zidovudine (ZDV)-experienced compared with ZDV-naive patients.
AIDS (London, England) 1999;13(2):225-9.
1999: Cromwell D M; Bass E B; Steinberg E P; Yasui Y; Ravich W J; Hendrix T R; McLeod S F; Moore R D
Can restrictions on reimbursement for anti-ulcer drugs decrease Medicaid pharmacy costs without increasing hospitalizations?
Health services research 1999;33(6):1593-610.
1999: Moore R D; Cheever L; Keruly J C; Chaisson R E
Lack of sex difference in CD4 to HIV-1 RNA viral load ratio.
Lancet 1999;353(9151):463-4.
1999: Moore R D
Schistocytosis and a thrombotic microangiopathy-like syndrome in hospitalized HIV-infected patients.
American journal of hematology 1999;60(2):116-20.
1998: Lumadue J A; Manabe Y C; Moore R D; Belitsos P C; Sears C L; Clark D P
A clinicopathologic analysis of AIDS-related cryptosporidiosis.
AIDS (London, England) 1998;12(18):2459-66.
1998: Sulkowski M S; Chaisson R E; Karp C L; Moore R D; Margolick J B; Quinn T C
The effect of acute infectious illnesses on plasma human immunodeficiency virus (HIV) type 1 load and the expression of serologic markers of immune activation among HIV-infected adults.
The Journal of infectious diseases 1998;178(6):1642-8.
1998: Gallant J E; Chaisson R E; Moore R D
The effect of adjunctive corticosteroids for the treatment of Pneumocystis carinii pneumonia on mortality and subsequent complications.
Chest 1998;114(5):1258-63.
1998: Moore R
HIV therapy and prevention: economics and cost-effectiveness.
The Hopkins HIV report : a bimonthly newsletter for healthcare providers / Johns Hopkins University AIDS Service 1998;10(5):2, 10-1.
1998: Bates D W; Parsonnet J; Ketchum P A; Miller E B; Novitsky T J; Sands K; Hibberd P L; Graman P S; Lanken P N; Schwartz J S; Kahn K; Snydman D R; Moore R; Black E; Platt R
Limulus amebocyte lysate assay for detection of endotoxin in patients with sepsis syndrome. AMCC Sepsis Project Working Group.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;27(3):582-91.
1998: Manabe Y C; Clark D P; Moore R D; Lumadue J A; Dahlman H R; Belitsos P C; Chaisson R E; Sears C L
Cryptosporidiosis in patients with AIDS: correlates of disease and survival.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;27(3):536-42.
1998: Moore R D; Keruly J C; Chaisson R E
Anemia and survival in HIV infection.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1998;19(1):29-33.
1998: Sterling T R; Moore R D; Graham N M; Astemborski J; Vlahov D; Chaisson R E
Mycobacterium tuberculosis infection and disease are not associated with protection against subsequent disseminated M. avium complex disease.
AIDS (London, England) 1998;12(12):1451-7.
1998: Celentano D D; Vlahov D; Cohn S; Shadle V M; Obasanjo O; Moore R D
Self-reported antiretroviral therapy in injection drug users.
JAMA : the journal of the American Medical Association 1998;280(6):544-6.
1998: Bartlett J G; Moore R D
Improving HIV therapy.
Scientific American 1998;279(1):84-7, 89.
1998: Eldred L J; Wu A W; Chaisson R E; Moore R D
Adherence to antiretroviral and pneumocystis prophylaxis in HIV disease.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1998;18(2):117-25.
1998: Lucas G M; Lechtzin N; Puryear D W; Yau L L; Flexner C W; Moore R D
Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;26(5):1127-33.
1998: Mundy L M; Oldach D; Auwaerter P G; Gaydos C A; Moore R D; Bartlett J G; Quinn T C
Implications for macrolide treatment in community-acquired pneumonia. Hopkins CAP Team.
Chest 1998;113(5):1201-6.
1998: Agnew D G; Lima A A; Newman R D; Wuhib T; Moore R D; Guerrant R L; Sears C L
Cryptosporidiosis in northeastern Brazilian children: association with increased diarrhea morbidity.
The Journal of infectious diseases 1998;177(3):754-60.
1998: Chaisson R E; Gallant J E; Keruly J C; Moore R D
Impact of opportunistic disease on survival in patients with HIV infection.
AIDS (London, England) 1998;12(1):29-33.
1998: Moore R D
Understanding the clinical and economic outcomes of HIV therapy: the Johns Hopkins HIV clinical practice cohort.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1998;17 Suppl 1():S38-41.
1997: Bates D W; Sands K; Miller E; Lanken P N; Hibberd P L; Graman P S; Schwartz J S; Kahn K; Snydman D R; Parsonnet J; Moore R; Black E; Johnson B L; Jha A; Platt R
Predicting bacteremia in patients with sepsis syndrome. Academic Medical Center Consortium Sepsis Project Working Group.
The Journal of infectious diseases 1997;176(6):1538-51.
1997: Mehta S; Moore R D; Graham N M
Potential factors affecting adherence with HIV therapy.
AIDS (London, England) 1997;11(14):1665-70.
1997: Moore R D; Chaisson R E
Cost-utility analysis of prophylactic treatment with oral ganciclovir for cytomegalovirus retinitis.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;16(1):15-21.
1997: Chambers F G; Koshy S S; Saidi R F; Clark D P; Moore R D; Sears C L
Bacteroides fragilis toxin exhibits polar activity on monolayers of human intestinal epithelial cells (T84 cells) in vitro.
Infection and immunity 1997;65(9):3561-70.
1997: Styrt B A; Chaisson R E; Moore R D
Prior antimicrobials and staphylococcal bacteremia in HIV-infected patients.
AIDS (London, England) 1997;11(10):1243-8.
1997: Dal Pan G J; Skolasky R L; Moore R D
The impact of neurologic disease on hospitalizations related to human immunodeficiency virus infection in Maryland, 1991-1992.
Archives of neurology 1997;54(7):846-52.
1997: Sands K E; Bates D W; Lanken P N; Graman P S; Hibberd P L; Kahn K L; Parsonnet J; Panzer R; Orav E J; Snydman D R; Black E; Schwartz J S; Moore R; Johnson B L; Platt R;
Epidemiology of sepsis syndrome in 8 academic medical centers.
JAMA : the journal of the American Medical Association 1997;278(3):234-40.
1997: Erbelding E J; Chaisson R E; Gallant J E; Moore R D
Acyclovir in combination with zidovudine does not prolong survival in advanced HIV disease.
Antiviral therapy 1997;2(2):71-7.
1997: Moore R D; Chaisson R E
Costs to Medicaid of advancing immunosuppression in an urban HIV-infected patient population in Maryland.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;14(3):223-31.
1997: Maenza J R; Merz W G; Romagnoli M J; Keruly J C; Moore R D; Gallant J E
Infection due to fluconazole-resistant Candida in patients with AIDS: prevalence and microbiology.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(1):28-34.
1997: Chaisson R E; Moore R D
Prevention of opportunistic infections in the era of improved antiretroviral therapy.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1997;16 Suppl 1():S14-22.
1996: Charache S; Barton F B; Moore R D; Terrin M L; Steinberg M H; Dover G J; Ballas S K; McMahon R P; Castro O; Orringer E P
Hydroxyurea and sickle cell anemia. Clinical utility of a myelosuppressive "switching" agent. The Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
Medicine 1996;75(6):300-26.
1996: Moore R D; Chaulk C P; Griffiths R; Cavalcante S; Chaisson R E
Cost-effectiveness of directly observed versus self-administered therapy for tuberculosis.
American journal of respiratory and critical care medicine 1996;154(4 Pt 1):1013-9.
1996: Moore R D; Bartlett J G
Combination antiretroviral therapy in HIV infection. An economic perspective.
PharmacoEconomics 1996;10(2):109-13.
1996: Moore R D; Fortgang I; Keruly J; Chaisson R E
Adverse events from drug therapy for human immunodeficiency virus disease.
The American journal of medicine 1996;101(1):34-40.
1996: Moore R D; Keruly J C; Chaisson R E
Duration of the survival benefit of zidovudine therapy in HIV infection.
Archives of internal medicine 1996;156(10):1073-7.
1996: Moore R D; Chaisson R E
Natural history of opportunistic disease in an HIV-infected urban clinical cohort.
Annals of internal medicine 1996;124(7):633-42.
1996: Chaisson R E; Keruly J C; McAvinue S; Gallant J E; Moore R D
Effects of an incentive and education program on return rates for PPD test reading in patients with HIV infection.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1996;11(5):455-9.
1996: Gebo K A; Moore R D; Keruly J C; Chaisson R E
Risk factors for pneumococcal disease in human immunodeficiency virus-infected patients.
The Journal of infectious diseases 1996;173(4):857-62.
1996: Auwaerter P G; Oldach D; Mundy L M; Burton A; Warner M L; Vance E; Moore R D; Rossi C A
Hantavirus serologies in patients hospitalized with community-acquired pneumonia.
The Journal of infectious diseases 1996;173(1):237-9.
1996: Maenza J R; Keruly J C; Moore R D; Chaisson R E; Merz W G; Gallant J E
Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients.
The Journal of infectious diseases 1996;173(1):219-25.
1995: Charache S; Terrin M L; Moore R D; Dover G J; McMahon R P; Barton F B; Waclawiw M; Eckert S V
Design of the multicenter study of hydroxyurea in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea.
Controlled clinical trials 1995;16(6):432-46.
1995: Moore R D; Chaisson R E
Survival analysis of two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex in AIDS.
AIDS (London, England) 1995;9(12):1337-42.
1995: Manabe Y C; Vinetz J M; Moore R D; Merz C; Charache P; Bartlett J G
Clostridium difficile colitis: an efficient clinical approach to diagnosis.
Annals of internal medicine 1995;123(11):835-40.
1995: Moore R D; Keruly J C; Chaisson R E
Neutropenia and bacterial infection in acquired immunodeficiency syndrome.
Archives of internal medicine 1995;155(18):1965-70.
1995: Mundy L M; Auwaerter P G; Oldach D; Warner M L; Burton A; Vance E; Gaydos C A; Joseph J M; Gopalan R; Moore R D
Community-acquired pneumonia: impact of immune status.
American journal of respiratory and critical care medicine 1995;152(4 Pt 1):1309-15.
1995: Fortgang I S; Belitsos P C; Chaisson R E; Moore R D
Hepatomegaly and steatosis in HIV-infected patients receiving nucleoside analog antiretroviral therapy.
The American journal of gastroenterology 1995;90(9):1433-6.
1995: Chaisson R E; Keruly J C; Moore R D
Race, sex, drug use, and progression of human immunodeficiency virus disease.
The New England journal of medicine 1995;333(12):751-6.
1995: Glesby M J; Moore R D; Chaisson R E
Clinical spectrum of herpes zoster in adults infected with human immunodeficiency virus.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21(2):370-5.
1995: Gallant J E; Moore R D; Keruly J; Richman D D; Chaisson R E
Lack of association between acyclovir use and survival in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group.
The Journal of infectious diseases 1995;172(2):346-52.
1995: Charache S; Terrin M L; Moore R D; Dover G J; Barton F B; Eckert S V; McMahon R P; Bonds D R
Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.
The New England journal of medicine 1995;332(20):1317-22.
1995: Fortgang I S; Moore R D
Hospital admissions of HIV-infected patients from 1988 to 1992 in Maryland.
Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association 1995;8(4):365-72.
1995: Gallant J E; McAvinue S M; Moore R D; Bartlett J G; Stanton D L; Chaisson R E
The impact of prophylaxis on outcome and resource utilization in Pneumocystis carinii pneumonia.
Chest 1995;107(4):1018-23.
1995: Chang Y C; Smith K D; Moore R D; Serjeant G R; Dover G J
An analysis of fetal hemoglobin variation in sickle cell disease: the relative contributions of the X-linked factor, beta-globin haplotypes, alpha-globin gene number, gender, and age.
Blood 1995;85(4):1111-7.
1994: Moore R D; Chaisson R E; Hidalgo J
The efficacy of zidovudine is time limited.
JAMA : the journal of the American Medical Association 1994;272(13):1001; author reply 1001-2.
1994: Stanton D L; Wu A W; Moore R D; Rucker S C; Piazza M P; Abrams J E; Chaisson R E
Functional status of persons with HIV infection in an ambulatory setting.
Journal of acquired immune deficiency syndromes 1994;7(10):1050-6.
1994: Gallant J E; Moore R D; Chaisson R E
Prophylaxis for opportunistic infections in patients with HIV infection.
Annals of internal medicine 1994;120(11):932-44.
1994: Moore R D; Hidalgo J; Bareta J C; Chaisson R E
Zidovudine therapy and health resource utilization in AIDS.
Journal of acquired immune deficiency syndromes 1994;7(4):349-54.
1994: Gallant J E; Moore R D; Richman D D; Keruly J; Chaisson R E
Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group.
Archives of internal medicine 1994;154(5):566-72.
1994: Moore R D; Stanton D; Gopalan R; Chaisson R E
Racial differences in the use of drug therapy for HIV disease in an urban community.
The New England journal of medicine 1994;330(11):763-8.
1994: Moore R D
Screening and assessment of alcohol and other drug abuse.
Maryland medical journal (Baltimore, Md. : 1985) 1994;43(1):35-9.
1993: Powe N R; Moore R D; Steinberg E P
Adverse reactions to contrast media: factors that determine the cost of treatment.
AJR. American journal of roentgenology 1993;161(5):1089-95.
1993: Glesby M J; Moore R D; Chaisson R E
Herpes zoster in patients with advanced human immunodeficiency virus infection treated with zidovudine. Zidovudine Epidemiology Study Group.
The Journal of infectious diseases 1993;168(5):1264-8.
1993: Powe N R; Davidoff A J; Moore R D; Brinker J A; Anderson G F; Litt M R; Gopalan R; Graziano S L; Steinberg E P
Net costs from three perspectives of using low versus high osmolality contrast medium in diagnostic angiocardiography.
Journal of the American College of Cardiology 1993;21(7):1701-9.
1993: Chaisson R E; Stanton D L; Gallant J E; Rucker S; Bartlett J G; Moore R D
Impact of the 1993 revision of the AIDS case definition on the prevalence of AIDS in a clinical setting.
AIDS (London, England) 1993;7(6):857-62.
1993: Wright C; Moore R D; Grodin D M; Spyker D A; Gill E V
Screening for disulfiram-induced liver test dysfunction in an inpatient alcoholism program.
Alcoholism, clinical and experimental research 1993;17(1):184-6.
1993: Baldwin W A; Rosenfeld B A; Breslow M J; Buchman T G; Deutschman C S; Moore R D
Substance abuse-related admissions to adult intensive care.
Chest 1993;103(1):21-5.
1992: Gallant J E; Moore R D; Richman D D; Keruly J; Chaisson R E
Incidence and natural history of cytomegalovirus disease in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
The Journal of infectious diseases 1992;166(6):1223-7.
1992: Chaisson R E; Keruly J; Richman D D; Moore R D
Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Archives of internal medicine 1992;152(10):2009-13.
1992: Chaisson R E; Moore R D; Richman D D; Keruly J; Creagh T
Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
The American review of respiratory disease 1992;146(2):285-9.
1992: Moore R D; Keruly J; Richman D D; Creagh-Kirk T; Chaisson R E
Natural history of advanced HIV disease in patients treated with zidovudine. The Zidovudine Epidemiology Study Group.
AIDS (London, England) 1992;6(7):671-7.
1992: Kimball A W; Friedman L A; Moore R D
Nonlinear modeling of alcohol consumption for analysis of beverage type effects and beverage preference effects.
American journal of epidemiology 1992;135(11):1287-92.
1992: Charache S; Dover G J; Moore R D; Eckert S; Ballas S K; Koshy M; Milner P F; Orringer E P; Phillips G; Platt O S
Hydroxyurea: effects on hemoglobin F production in patients with sickle cell anemia.
Blood 1992;79(10):2555-65.
1992: Gopalan R; Santora P; Stokes E J; Moore R D; Levine D M
Evaluation of a model curriculum on substance abuse at The Johns Hopkins University School of Medicine.
Academic medicine : journal of the Association of American Medical Colleges 1992;67(4):260-6.
1992: Moore R D; Lerner S A; Levine D P
Nephrotoxicity and ototoxicity of aztreonam versus aminoglycoside therapy in seriously ill nonneutropenic patients.
The Journal of infectious diseases 1992;165(4):683-8.
1992: Moore R D; Steinberg E P; Powe N R; Brinker J A; Fishman E K; Graziano S; Gopalan R
Nephrotoxicity of high-osmolality versus low-osmolality contrast media: randomized clinical trial.
Radiology 1992;182(3):649-55.
1992: Steinberg E P; Moore R D; Powe N R; Gopalan R; Davidoff A J; Litt M; Graziano S; Brinker J A
Safety and cost effectiveness of high-osmolality as compared with low-osmolality contrast material in patients undergoing cardiac angiography.
The New England journal of medicine 1992;326(7):425-30.
1991: Easterbrook P J; Keruly J C; Creagh-Kirk T; Richman D D; Chaisson R E; Moore R D
Racial and ethnic differences in outcome in zidovudine-treated patients with advanced HIV disease. Zidovudine Epidemiology Study Group.
JAMA : the journal of the American Medical Association 1991;266(19):2713-8.
1991: Sanders J W; Powe N R; Moore R D
Ceftazidime monotherapy for empiric treatment of febrile neutropenic patients: a meta-analysis.
The Journal of infectious diseases 1991;164(5):907-16.
1991: Steinberg E P; Moore R D; Brinker J A; Fishman E K; Powe N R; Graziano S L; Gopalan R
Nephrotoxicity of low osmolality contrast media versus high osmolality media.
Investigative radiology 1991;26 Suppl 1():S86; discussion S88-91.
1991: Brinker J; Steinberg E; Moore R; Powe N; Graziano S; Gopalan R; Litt M
The effects of intracoronary contrast in the denervated human heart.
Investigative radiology 1991;26 Suppl 1():S118-9; discussion S125-8.
1991: Umbricht-Schneiter A; Santora P; Moore R D
Alcohol abuse: comparison of two methods for assessing its prevalence and associated morbidity in hospitalized patients.
The American journal of medicine 1991;91(2):110-8.
1991: Moore R D; Hidalgo J; Sugland B W; Chaisson R E
Zidovudine and the natural history of the acquired immunodeficiency syndrome.
The New England journal of medicine 1991;324(20):1412-6.
1991: Moore R D; Kessler H; Richman D D; Flexner C; Chaisson R E
Non-Hodgkin's lymphoma in patients with advanced HIV infection treated with zidovudine.
JAMA : the journal of the American Medical Association 1991;265(17):2208-11.
1991: Moore R D; Creagh-Kirk T; Keruly J; Link G; Wang M C; Richman D; Chaisson R E
Long-term safety and efficacy of zidovudine in patients with advanced human immunodeficiency virus disease. Zidovudine Epidemiology Study Group.
Archives of internal medicine 1991;151(5):981-6.
1991: Livingston I L; Levine D M; Moore R D
Social integration and black intraracial variation in blood pressure.
Ethnicity & disease 1991;1(2):135-49.
1990: Wright C; Moore R D
Disulfiram treatment of alcoholism.
The American journal of medicine 1990;88(6):647-55.
1990: Moore R D; Mead L; Pearson T A
Youthful precursors of alcohol abuse in physicians.
The American journal of medicine 1990;88(4):332-6.
1990: Moore R D; Levine D M; Southard J; Entwisle G; Shapiro S
Alcohol consumption and blood pressure in the 1982 Maryland Hypertension Survey.
American journal of hypertension 1990;3(1):1-7.
1990: Klag M J; Moore R D; Whelton P K; Sakai Y; Comstock G W
Alcohol consumption and blood pressure: a comparison of native Japanese to American men.
Journal of clinical epidemiology 1990;43(12):1407-14.
1989: Klag M J; Moore R D; Sakai Y; Sasaki S; Stone R W; Comstock G W
Alcohol use and retinal vessels: insights into the mechanism of alcohol-induced stroke.
International journal of epidemiology 1989;18(3):619-25.
1989: Geller G; Levine D M; Mamon J A; Moore R D; Bone L R; Stokes E J
Knowledge, attitudes, and reported practices of medical students and house staff regarding the diagnosis and treatment of alcoholism.
JAMA : the journal of the American Medical Association 1989;261(21):3115-20.
1989: Curtis J R; Geller G; Stokes E J; Levine D M; Moore R D
Characteristics, diagnosis, and treatment of alcoholism in elderly patients.
Journal of the American Geriatrics Society 1989;37(4):310-6.
1989: Moore R D; Steinberg E P; Powe N R; White R I; Brinker J A; Fishman E K; Zinreich S J; Smith C R
Frequency and determinants of adverse reactions induced by high-osmolality contrast media.
Radiology 1989;170(3 Pt 1):727-32.
1989: Moore R D; Bone L R; Geller G; Mamon J A; Stokes E J; Levine D M
Prevalence, detection, and treatment of alcoholism in hospitalized patients.
JAMA : the journal of the American Medical Association 1989;261(3):403-7.
1988: Powe N R; Steinberg E P; Erickson J E; Moore R D; Smith C R; White R I; Brinker J A; Fishman E K; Zinreich S J; Kinnison M L
Contrast medium-induced adverse reactions: economic outcome.
Radiology 1988;169(1):163-8.
1988: Moore R D; Smith C R; Kwiterovich P O; Pearson T A
Effect of low-dose alcohol use versus abstention on apolipoproteins A-I and B.
The American journal of medicine 1988;84(5):884-90.
1987: Moore R D; Lietman P S; Smith C R
Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration.
The Journal of infectious diseases 1987;155(1):93-9.
1986: Smith C R; Moore R D; Lietman P S
Studies of risk factors for aminoglycoside nephrotoxicity.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1986;8(5):308-13.
1986: Moore R D; Smith C R; Lietman P S
Predicting aminoglycoside nephrotoxicity.
JAMA : the journal of the American Medical Association 1986;256(7):864-6.
1986: Moore R D; Smith C R; Lietman P S
Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides.
The American journal of medicine 1986;80(6):1093-7.
1986: Sawyers C L; Moore R D; Lerner S A; Smith C R
A model for predicting nephrotoxicity in patients treated with aminoglycosides.
The Journal of infectious diseases 1986;153(6):1062-8.
1986: Moore R D; Smith C R; Holloway J J; Lietman P S
Cefotaxime vs nafcillin and tobramycin for the treatment of serious infection. Comparative cost-effectiveness.
Archives of internal medicine 1986;146(6):1153-7.
1985: Ambinder R F; Moore R D; Smith C R; Mellits E D; Lietman P S
Lack of evidence for interaction between tobramycin and shock in their effect on renal function.
Antimicrobial agents and chemotherapy 1985;27(2):217-9.
1984: Holloway J J; Smith C R; Moore R D; Feroli E R; Lietman P S
Comparative cost effectiveness of gentamicin and tobramycin.
Annals of internal medicine 1984;101(6):764-9.
1984: Moore R D; Smith C R; Lietman P S
Association of aminoglycoside plasma levels with therapeutic outcome in gram-negative pneumonia.
The American journal of medicine 1984;77(4):657-62.
1984: Moore R D; Smith C R; Lietman P S
The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia.
The Journal of infectious diseases 1984;149(3):443-8.
1984: Moore R D; Smith C R; Lipsky J J; Mellits E D; Lietman P S
Risk factors for nephrotoxicity in patients treated with aminoglycosides.
Annals of internal medicine 1984;100(3):352-7.
1984: Moore R D; Smith C R; Lietman P S
Risk factors for the development of auditory toxicity in patients receiving aminoglycosides.
The Journal of infectious diseases 1984;149(1):23-30.
1983: Klein L E; Levine D M; Moore R D; Kirby S M
The preoperative consultation. Response to internists' recommendations.
Archives of internal medicine 1983;143(4):743-4.
1983: Klein L E; Moore R D; Levine D M; Kirby S
Effectiveness of medical consultation.
Journal of medical education 1983;58(2):149-51.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Richard Moore

Research Profile (preview)

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Living Beings

Geographic Areas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Richard Moore (preview)

All Publications